FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
“FDA Approved Drugs With Antiviral Activity Against SARS-CoV-2: From Structure-Based Repurposing to Host-Specific Mechanisms”. 2023. Biomedicine & Pharmacotherapy.